NCT06623500 Iodine Nutrition Status and Clinical Characteristics of Thyroid Cancer
| NCT ID | NCT06623500 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Shandong Provincial Hospital |
| Condition | Thyroid Cancer |
| Study Type | OBSERVATIONAL |
| Enrollment | 1,600 participants |
| Start Date | 2012-01-01 |
| Primary Completion | 2026-12-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 1,600 participants in total. It began in 2012-01-01 with a primary completion date of 2026-12-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The effect of iodine nutritional status on thyroid cancer has been controversial for many years. We designed a prospective cohort study that recruiting patients in different iodine areas who underwent thyroid cancer surgery in branch hospitals from 2012 to 2019，and follow up their clinical outcomes. We aimed to analyse the relationship between regional iodine nutrition level and pathological types, clinical features, and prognosis of thyroid cancer.
Eligibility Criteria
Inclusion Criteria: 1. Age range: 18\~65 years old, gender not limited; 2. Living in the selected region for at least 5 years; 3. Patients who underwent thyroid surgery at various research centers were pathologically diagnosed with thyroid cancer; 4. The clinical data （general information、surgical scope 、pathological report、utrasonic report, etc ）of the case is complete. Exclusion Criteria: 1. Diagnosed as other types of cancer or thyroid metastatic cancer; 2. There are serious comorbidities such as heart, liver, and kidney diseases present; 3. Unable to follow up on prognostic information.
Contact & Investigator
Frequently Asked Questions
Who can join the NCT06623500 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 65 Years, studying Thyroid Cancer. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06623500 currently recruiting?
Yes, NCT06623500 is actively recruiting participants. Contact the research team at guoqinglingqhb@163.com for enrollment information.
Where is the NCT06623500 trial being conducted?
This trial is being conducted at Jinan, China.
Who is sponsoring the NCT06623500 clinical trial?
NCT06623500 is sponsored by Shandong Provincial Hospital. The trial plans to enroll 1,600 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.